Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and fluorodeoxyglucose f18

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with fluorodeoxyglucose f18 in 4 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Studies
(fluorodeoxyglucose f18)		Trials
(fluorodeoxyglucose f18)		Recent Studies (post-2010) (fluorodeoxyglucose f18)
330403334,7712,16020,111

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dresel, S; Horak, M; Rüther, T; Soyka, M; Tatsch, K1
Amthauer, H; Felix, R; Harnack, D; Klaffke, S; Kuhn, AA; Kupsch, A; Plotkin, M1
Afzal, W; Apostolova, I; Buchert, R; Buhmann, C; Derlin, T; Hesse, S; Klutmann, S; Meyer, PT; Wilke, F1
Hermann, W1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and fluorodeoxyglucose f18

ArticleYear
Morphological and functional imaging in neurological and non-neurological Wilson's patients.
    Annals of the New York Academy of Sciences, 2014, Volume: 1315

    Topics: Benzamides; Brain; Cocaine; Copper; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2014

Other Studies

3 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and fluorodeoxyglucose f18

ArticleYear
PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2000, Volume: 1, Issue:4

    Topics: Alcoholism; Benzamides; Brain; Fluorodeoxyglucose F18; Hallucinations; Humans; Iodine Radioisotopes; Male; Middle Aged; Pyrrolidines; Radiopharmaceuticals; Serotonin; Syndrome; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

2000
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10

    Topics: Aged; Benzamides; Blood Glucose; Brain; Cerebral Cortex; Cocaine; Corpus Striatum; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes

2006
IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.
    Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:4

    Topics: Benzamides; Diagnosis, Differential; Dopamine Antagonists; Fluorodeoxyglucose F18; Humans; Observer Variation; Parkinsonian Disorders; Patient Selection; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon

2010